EUVIMEDEUVIMED entdecken
Crossref

Gastrointestinal stromal tumours: incidence, recurrence and mortality. A decade of patients from a New Zealand tertiary surgical centre

Joshua Kirkpatrick iD, Yijiao Wang, Josiah Tu'inukuafe, Philip Chao, Jason Robertson, Jonathan Koea iD, Sanket Srinivasa

ANZ Journal of Surgery · 2024

DOI: 10.1111/ans.19195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2024. Verfasst von Joshua Kirkpatrick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, North Shore Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Neoplasm Recurrence, Local. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the gastrointestinal tract. The New Zealand (NZ) population incidence has not previously been documented nor has the potential effect of ethnicity been reviewed. We furthermore wanted to assess the difference between those undergoing a wedge resection versus a more extensive operation which we hypothesised would correlate with recurrence and mortality.

Methods

All patients ( n = 103) with a GIST diagnosed and treated at Te Whatu Ora Waitematā (Auckland, New Zealand) between 2012 and 2021 are presented. Patient demographics, method of GIST detection, management approach, index surgery, histological features, use of adjuvant and neoadjuvant imatinib, follow‐up, recurrence and mortality rates were analysed.

Results

This paper reports the largest NZ GIST cohort to date and estimates an incidence of 17 cases per million per year. Eighty‐four patients underwent surgical resection, 58 received a wedge resection and 17 received a more extensive operation. Five‐year disease‐free survival rates were 100% in the low/very low risk, 90% in the intermediate and 59% in the high risk groups as determined by the modified NIH criteria. Our overall 5‐year GIST‐specific survival rate was 83%; it was 91% in those who underwent a wedge resection and 60% in the extensive operation group. There is evidence that Māori have higher rates of GIST recurrence compared to non‐Māori and are more likely to require an extensive surgical resection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsNeoplasm Recurrence, LocalHumansNew ZealandFemaleMaleIncidenceMiddle AgedAgedAdultAged, 80 and overTertiary Care CentersGastrointestinal NeoplasmsSurvival RateDisease-Free SurvivalRetrospective StudiesImatinib Mesylate

Stichwörter der Autor:innen

New Zealandethnicitygastrointestinal stromal tumourgeneral surgeryincidencemortality ratesrecurrence ratesupper gut

Substanzen

Imatinib Mesylate

Autor:innen und Institutionen

  • Department of Surgery, North Shore Hospital, Auckland, New Zealand.

ORCID-Profile: Joshua Kirkpatrick, Jonathan Koea

Zitieren

APA

Kirkpatrick, J., Wang, Y., Tu'inukuafe, J., Chao, P., Robertson, J., Koea, J., & Srinivasa, S. (2024). Gastrointestinal stromal tumours: incidence, recurrence and mortality. A decade of patients from a New Zealand tertiary surgical centre. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19195

Vancouver

Kirkpatrick J, Wang Y, Tu'inukuafe J, Chao P, Robertson J, Koea J, et al. Gastrointestinal stromal tumours: incidence, recurrence and mortality. A decade of patients from a New Zealand tertiary surgical centre. ANZ Journal of Surgery. 2024. doi:10.1111/ans.19195

BibTeX
@article{Kirkpatrick2024,
  author = {Kirkpatrick, Joshua and Wang, Yijiao and Tu'inukuafe, Josiah and Chao, Philip and Robertson, Jason and Koea, Jonathan and Srinivasa, Sanket},
  title = {Gastrointestinal stromal tumours: incidence, recurrence and mortality. A decade of patients from a New Zealand tertiary surgical centre},
  journal = {ANZ Journal of Surgery},
  year = {2024},
  doi = {10.1111/ans.19195}
}
Kostenlos starten →